Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | SPENCER JOHN N JR | Oct 17, 2025 | Buy | $5.5K | 10,000 |
| Chief Medical Officer | McKee Kelly T. Jr. | Aug 7, 2025 | Buy | $741.69 | 1,107 |
| Director | SPENCER JOHN N JR | Apr 10, 2025 | Buy | $9.8K | 10,000 |
| VP, Business Development | Sharkey John W. | Apr 10, 2025 | Buy | $5.94K | 6,000 |
| CEO | DODD DAVID A | Apr 1, 2025 | Buy | $10.8K | 10,000 |
| CFO | Reynolds Mark | Mar 31, 2025 | Buy | $7.34K | 6,800 |
| CEO | DODD DAVID A | Aug 9, 2024 | Buy | $15.6K | 8,000 |
| CEO | DODD DAVID A | Feb 22, 2024 | Buy | $18.66K | 8,209 |
| CEO | DODD DAVID A | Feb 21, 2024 | Buy | $1.12K | 520 |
| CFO | Reynolds Mark | Feb 7, 2024 | Buy | $5.54K | 2,000 |
| Chief Medical Officer | McKee Kelly T. Jr. | Dec 22, 2023 | Buy | $2.5K | 6,944 |
| Chief Medical Officer | McKee Kelly T. Jr. | Sep 25, 2023 | Buy | $5.02K | 9,653 |
| CEO | DODD DAVID A | Aug 25, 2023 | Buy | $20K | 35,087 |
| CFO | Reynolds Mark | Aug 18, 2023 | Buy | $5.18K | 10,000 |
| CEO | DODD DAVID A | Apr 24, 2023 | Buy | $20.44K | 32,000 |
| CFO | Reynolds Mark | Apr 20, 2023 | Buy | $5.04K | 8,000 |
| Director | CHASE RANDAL D | Sep 21, 2022 | Buy | $11K | 10,000 |
| VP, Business Development | Sharkey John W. | Jul 1, 2022 | Buy | $820 | 1,000 |
| Chief Medical Officer | McKee Kelly T. Jr. | Jun 27, 2022 | Buy | $5K | 4,464 |
| Director | CHASE RANDAL D | Jun 21, 2022 | Buy | $12.1K | 10,000 |
| Chief Medical Officer | McKee Kelly T. Jr. | May 5, 2022 | Buy | $7K | 9,722 |
| Chief Medical Officer | McKee Kelly T. Jr. | May 4, 2022 | Buy | $3.55K | 4,999 |
| CFO | Reynolds Mark | Sep 29, 2020 | Buy | $300.92K | 60,184 |
| Director | Kollintzas Dean G | Sep 29, 2020 | Buy | $59.94K | 11,987 |
| Director | MCNALLY ROBERT T | Sep 29, 2020 | Buy | $269.63K | 53,925 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.